6326
K. Bravo-Altamirano et al. / Tetrahedron 61 (2005) 6315–6329
(d, JPCCCCCZ3 Hz), 133.1 (d, JPCCZ13 Hz, 2C), 117.4
(d, JPCZ142 Hz), 114.5 (d, JPCCCZ15 Hz, 2C), 65.4 (d,
JPOCZ6 Hz), 32.7 (d. JPOCCZ7 Hz), 19.0, 13.8; 31P NMR
(CDCl3) d 27.1 (dm, JZ559 Hz).
1H NMR (CDCl3) d 7.75–7.80 (m, 1H), 7.70–7.75 (m, 1H),
7.72 (d, JZ593 Hz, 1H), 7.25–7.30 (m, 1H), 4.10–4.20 (m,
2H), 1.70–1.80 (m, 2H), 1.40–1.50 (m, 2H), 0.95 (t, JZ
8 Hz, 3H); 13C NMR (CDCl3) d 136.7 (d, JPCCZ13 Hz),
134.5 (d, JPCSCZ6 Hz), 130.2 (d, JPCZ145 Hz), 128.5 (d,
JPCCCZ16 Hz), 65.8 (d, JPOCZ6 Hz), 32.4 (d, JPOCC
Z
4.5.7. Butyl [(4-tert-butoxycarbonylamino)phenyl]phos-
phinate (Table 2, entry 6). H NMR (CDCl3) d 7.86 (s,
1H), 7.70–7.75 (m, 2H), 7.60–7.65 (m, 2H), 7.56 (d, JZ
564 Hz), 4.05–4.10 (m, 2H), 1.65–1.75 (m, 2H), 1.50 (s,
9H), 1.35–1.45 (m, 2H), 0.92 (t, JZ7 Hz); 13C NMR
7 Hz), 18.8, 13.6; 31P NMR (CDCl3) d 16.3 (dm, JZ
593 Hz); HRMS (FAB) calcd for C8H13O2PS, (MCLi)C
211.0534, found 211.0531.
1
(CDCl3) d 152.6, 143.6 (d, JPCCCCZ3 Hz), 132.2 (d, JPCC
Z
4.5.13. Butyl 3-quinolinylphosphinate (Table 2, entry
12). 1H NMR (CDCl3) d 9.15 (dd, JZ5, 2 Hz, 1H), 8.71 (d,
JZ15 Hz, 1H), 8.19 (d, JZ9 Hz, 1H), 7.95 (d, JZ8 Hz,
1H), 7.85–7.90 (m, 1H), 7.82 (d, JZ573 Hz, 1H), 7.65–7.70
(m, 1H), 4.15–4.25 (m, 2H), 1.75–1.85 (m, 2H), 1.40–1.55
(m, 2H), 0.96 (t, JZ7 Hz, 3H); 13C NMR (CDCl3) d 149.7,
149.6, 142.1 (d, JPCCZ10 Hz), 132.3, 129.6, 128.8, 127.9,
126.7 (d, JPCCZ12 Hz), 123.0 (d, JPCZ131 Hz), 66.4 (d,
JPOCZ7 Hz), 32.5 (d, JPOCCZ6 Hz), 18.8, 13.6; 31P NMR
(CDCl3) d 25.9 (dm, JZ561 Hz); HRMS (FAB) calcd for
C13H16NO2P, (MCLi)C 256.1079, found 256.1072.
13 Hz), 123 (d, JPCZ138 Hz), 118.0 (d, JPCCCZ14 Hz),
80.9, 65.5 (d, JPOCZ7 Hz), 32.4 (d, JPOCCZ6 Hz), 28.3,
18.8, 13.6; 31P NMR (CDCl3) d 26.1 (dm, JZ565 Hz);
HRMS (FAB) calcd for C15H24NO4P, (MCLi)C 320.1603,
found 320.1610.
4.5.8. Butyl 1-naphthylphosphinate (Table 2, entry 7). 1H
NMR (CDCl3) d 8.43 (d, JZ8 Hz, 1H), 8.11 (dd, JZ7,
1 Hz, 1H), 8.05 (dd, JZ7, 4 Hz, 1H), 7.91 (d, JZ563 Hz,
1H), 7.90 (d, JZ8 Hz, 1H), 7.50–7.65 (m, 3H), 4.05–4.20
(m, 2H), 1.60–1.75 (m, 2H), 1.30–1.45 (m, 2H), 0.87 (t, JZ
7 Hz, 3H); 13C NMR (CDCl3) d 134.1 (d, JPCCCCZ3 Hz),
133.6 (d, JPCCZ10 Hz), 132.7 (d, JPCCZ13 Hz), 132.5,
4.5.14. Butyl 4-isoquinolinylphosphinate (Table 2, entry
13). 1H NMR (CDCl3) d 9.44 (d, JZ2 Hz, 1H), 8.98 (d, JZ
11 Hz, 1H), 8.46 (d, JZ9 Hz, 1H), 8.09 (d, JZ8 Hz, 1H),
7.98 (d, JZ570 Hz, 1H), 7.85–7.90 (m, 1H), 7.70–7.80
(m, 1H), 4.15–4.25 (m, 2H), 1.70–1.80 (m, 2H), 1.40–1.50
(m, 2H), 0.92 (t, JZ7 Hz, 3H); 13C NMR (CDCl3) d 157.7
(d, JPCCNCZ9 Hz), 147.8 (d, JPCCZ16 Hz), 134.8 (d,
JPCCZ9 Hz), 132.3, 128.8, 128.3, 128.0 (d, JPCCCZ8 Hz),
124.2 (d, JPCCCZ6 Hz), 119.9 (d, JPCZ121 Hz), 66.3 (d,
JPOCZ6 Hz), 32.4 (d, JPOCCZ6 Hz), 18.8, 13.5; 31P NMR
(CDCl3) d 24.3 (dm, JZ570 Hz); HRMS (FAB) calcd for
C13H16NO2P, (MCLi)C 256.1079, found 256.1086.
129.2 (d, JPCCCZ2 Hz), 128.0, 126.9, 126.2 (d, JPC
Z
Z
129 Hz), 125.0 (d, JPCCCCZ1 Hz), 124.8 (d, JPCCC
11 Hz); 31P NMR (CDCl3) d 27.1 (dm, JZ563 Hz);
HRMS (FAB) calcd for C14H17O2P, (MCLi)C 255.1126,
found 255.1138.
4.5.9. Ethyl 2-naphthylphosphinate (Table 2, entry 8). 1H
NMR (CDCl3) d 8.40 (d, JZ16 Hz, 1H), 7.95–8.00 (m, 2H),
7.90 (d, JZ9 Hz, 1H), 7.72 (d, JZ564 Hz, 1H), 7.65–7.80
(m, 1H), 7.60–7.65 (m, 2H); 4.15–4.25 (m, 2H), 1.41 (t, JZ
7 Hz, 3H); 13C NMR (CDCl3) d 135.6 (d, JPCCCCZ3 Hz),
133.7 (d, JPCCCZ12 Hz), 132.6 (d, JPCCZ15 Hz), 129.1 (d,
JPCCCZ3 Hz), 128.9, 128.8, 128.2, 127.1 (d, JPCZ132 Hz),
127.4, 125.4 (d, JPCCZ12 Hz), 62.3 (d, JPOCZ6 Hz), 16.7
(d, JPOCCZ6 Hz); 31P NMR (CDCl3) d 25.8 (dm, JZ
565 Hz).
4.5.15. Butyl benzylphosphinate (Table 3, entry 1).22 1
H
NMR (CDCl3) d 7.20–7.35 (m, 5H), 7.03 (d, JZ544 Hz,
1H), 3.90–4.10 (m, 2H), 3.19 (d, JZ18 Hz, 2H), 1.55–1.65
(m, 2H), 1.25–1.40 (m, 2H), 0.89 (t, JZ7 Hz, 3H); 13C
NMR (CDCl3) d 129.9, 129.8 (d, JPCCCZ7 Hz), 128.9 (d,
JPCCCCZ3 Hz), 127.7 (d, JPCCCCCZ4 Hz), 66.4 (d, JPOC
Z
4.5.10. Butyl (4-cyanophenyl)phosphinate (Table 2,
entry 9). 1H NMR (CDCl3) d 7.90–8.00 (m, 2H),
7.80w7.90 (m, 2H), 7.65 (d, JZ574 Hz, 1H), 4.10–4.20
(m, 2H), 1.70–1.80 (m, 2H), 1.40–1.50 (m, 2H), 0.95 (t, JZ
7 Hz, 3H); 13C NMR (CDCl3) d 135.0 (d, JPCZ129 Hz),
132.3 (d, JPCCCZ14 Hz), 131.6 (d, JPCCZ12 Hz), 117.7,
116.7 (d, JPCCCCZ3 Hz), 66.5 (d, JPOCZ7 Hz), 32.4 (d,
JPOCCZ6 Hz), 18.7, 13.5; 31P NMR (CDCl3) d 22.5 (dm,
JZ574 Hz); HRMS (FAB) calcd for C11H14NO2P, (MC
Li)C 230.0922, found 230.0917.
7 Hz), 37.0 (d, JPCZ89 Hz), 32.3 (d, JPOCCZ6 Hz), 18.7,
13.5; 31P NMR (CDCl3) d 37.9 (dm, JZ545 Hz); HRMS
(FAB) calcd for C11H17O2P, (MCLi)C 219.1126, found
219.1125.
4.5.16. Butyl (4-methoxybenzyl)phosphinate (Table 3,
1
entry 2). H NMR (CDCl3) d 7.15 (dd, JZ9 Hz, JZ3 Hz,
2H), 7.0 (d, JZ542 Hz, 1H), 6.87 (d, JZ8 Hz, 2H), 3.9–
4.15 (m, 2H), 3.8 (s, 3H), 3.14 (d, JZ18 Hz, 2H), 1.58–1.68
(m, 2H), 1.28–1.42 (m, 2H), 0.91 (t, JZ7 Hz, 3H); 13C
NMR (CDCl3) d 159.0 (d, JPCCCCCZ4 Hz), 131.0 (d,
JPCCCZ6 Hz, 2C), 121.8 (d, JPCCZ8 Hz), 114.6 (d,
JPCCCCZ3 Hz, 2C), 66.7 (d, JPOCZ7 Hz), 55.5, 36.2 (d,
JPCZ90 Hz), 32.6 (d, JPOCCZ6 Hz), 18.9, 13.8; 31P NMR
(CDCl3) d 40.2 (dm, JZ542 Hz); HRMS (EIC) calcd for
C12H19O3P, (M)C 242.1072, found 242.1069.
4.5.11. Butyl 3-pyridinylphosphinate (Table 2, entry 10).
1H NMR (CDCl3) d 8.98 (dm, JZ7 Hz, 1H), 8.85 (m, 1H),
8.10–8.20 (m, 1H), 7.45–7.50 (m, 1H), 7.69 (d, JZ573 Hz,
1H), 4.15–4.20 (m, 2H), 1.70–1.80 (m, 2H), 1.40–1.50 (m,
2H), 0.96 (t, JZ7 Hz, 3H); 13C NMR (CDCl3) d 153.7 (d,
JPCCNCZ2 Hz), 151.8 (d, JPCCZ14 Hz), 139.0 (d, JPCC
Z
10 Hz), 126.2 (d, JPCZ131 Hz), 123.7 (d, JPCCCZ10 Hz),
4.5.17. Butyl (pyridin-3-yl-methyl)phosphinate (Table 3,
entry 3). 1H NMR (CDCl3) d 8.50–8.55 (m, 2H), 7.60–7.65
(m, 1H), 7.25–7.35 (m, 1H), 7.12 (d, JZ548 Hz, 1H), 4.00–
4.15 (m, 2H), 3.20 (d, JZ18 Hz, 2H), 1.60–1.70 (m, 2H),
1.30–1.40 (m, 2H), 0.92 (t, JZ7 Hz, 3H); 13C NMR
66.4 (d, JPOCZ7 Hz), 32.4 (d, JPOCCZ7 Hz), 18.8, 13.6; 31
NMR (CDCl3) d 22.0 (dm, JZ573 Hz).
P
4.5.12. Butyl 2-thienylphosphinate (Table 2, entry 11).